Speakers Benjamin Lightburn

Benjamin Lightburn, CEO/Co-Founder of Filament Health, will speak about the myriad benefits a botanical approach to drug development offers. Filament believes that safe, natural psychedelic medicines will help more people, more quickly and effectively, than synthetic alternatives. This belief and the team’s extraction know-how has allowed the company to enter botanical psychedelic drug candidates into FDA clinical trials for the first time. Ben will explore novel natural drug candidates, the entourage effect, and natural’s role in the landscape